Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $19.1 million.

  • Veracyte's Consolidated Net Income rose 2633.35% to $19.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.3 million, marking a year-over-year increase of 42692.18%. This contributed to the annual value of $24.1 million for FY2024, which is 13244.18% up from last year.
  • Per Veracyte's latest filing, its Consolidated Net Income stood at $19.1 million for Q3 2025, which was up 2633.35% from -$980000.0 recorded in Q2 2025.
  • In the past 5 years, Veracyte's Consolidated Net Income registered a high of $19.1 million during Q3 2025, and its lowest value of -$41.9 million during Q1 2021.
  • Moreover, its 5-year median value for Consolidated Net Income was -$8.4 million (2023), whereas its average is -$7.2 million.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first crashed by 63033.04% in 2023, then surged by 47703.86% in 2025.
  • Over the past 5 years, Veracyte's Consolidated Net Income (Quarter) stood at -$10.5 million in 2021, then soared by 63.16% to -$3.9 million in 2022, then plummeted by 630.33% to -$28.3 million in 2023, then surged by 118.16% to $5.1 million in 2024, then soared by 272.53% to $19.1 million in 2025.
  • Its Consolidated Net Income was $19.1 million in Q3 2025, compared to -$980000.0 in Q2 2025 and $7.0 million in Q1 2025.